In small human clinical trials, antibodies targeting HIV completely suppress the virus. If the results pan out in larger studies, they could simplify treatment for people who have difficulty taking daily medication, reduce the risk of drug resistance, and cut HIV transmission rates.
No comments:
Post a Comment